Low Vitamin D Levels Up Risk for COVID-19 Hospitalization
By Lori Solomon HealthDay Reporter

THURSDAY, July 31, 2025 -- Vitamin D insufficiency and deficiency are tied to higher risk of being hospitalized for COVID-19, according to a study published online July 18 in PLOS ONE.
Maria J. Monroy-Iglesias, Ph.D., from King’s College London, and colleagues used data from the U.K. biobank (151,543 individuals with at least one serum vitamin D level measurement at baseline, 2006 to 2010) to assess associations between vitamin D levels and risk of COVID-19 infection and hospitalization.
The researchers found that vitamin D insufficiency (adjusted odds ratio [aOR], 0.97; 95 percent confidence interval [CI], 0.94 to 1.00) and deficiency (aOR, 0.95; 95 percent CI, 0.90 to 0.99) were associated with slightly lower odds of COVID-19 infection. There was variance by race and ethnicity, with Asian and Black participants having higher odds of COVID-19 infection with vitamin D deficiency, while vitamin D insufficiency in White participants was associated with slightly lower odds of COVID-19 infection. Both vitamin D insufficiency (aOR, 1.19; 95 percent CI, 1.08 to 1.32) and deficiency (aOR, 1.44; 95 percent CI, 1.25 to 1.66) were associated with higher odds of COVID-19 hospitalization.
"COVID-19 may not be the threat it once was, but it still affects peoples’ well-being," coauthor Kerri Beckmann, Ph.D., from the University of South Australia in Adelaide, said in a statement. "Understanding who is most at risk helps those individuals take extra precautions, including monitoring their vitamin D levels."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-01 06:00
Read more

- Pig Lung Transplanted Into Man for 9 Days in Groundbreaking Study
- Repeated Annual Exposure to Heatwaves May Accelerate Biological Aging
- FDA Approves Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the Treatment of Fibromyalgia
- Regeneron Announces Positive Results from Phase 3 Trial of Cemdisiran in Generalized Myasthenia Gravis
- One in 10 Mental Health-Related ED Visits Among Youths Involve Boarding
- Measles Outbreak in Texas Is Over After Hundreds Infected and 2 Deaths
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions